B G Utterback

In vitro vascular relaxation by new inotropic agents: relationship to phosphodiesterase inhibition and cyclic nucleotides.

Raymond F. Kauffman, Kathryn W. Schenck, B G Utterback et al. · Journal of Pharmacology and Experimental Therapeutics · 1987 · 124 citations

LY195115: a potent, selective inhibitor of cyclic nucleotide phosphodiesterase located in the sarcoplasmic reticulum.

Raymond F. Kauffman, V G Crowe, B G Utterback et al. · Molecular Pharmacology · 1986 · 84 citations

Pharmacological assessment of the antithrombotic activity of the peptide thrombin inhibitor, D-methyl-phenylalanyl-prolyl-arginal (GYKI-14766), in a canine model of coronary artery thrombosis.

Charles V. Jackson, V G Crowe, Judit Frank et al. · Journal of Pharmacology and Experimental Therapeutics · 1992 · 28 citations

Characterization and pharmacological relevance of high affinity binding sites for [3H]LY186126, a cardiotonic phosphodiesterase inhibitor, in canine cardiac membranes.

Raymond F. Kauffman, B G Utterback, David W. Robertson · Circulation Research · 1989 · 22 citations · Full text

Cardiac Muscle, Proteinlipid Interaction, Cardiovascular Pharmacology +21

Specific binding of [3H]LY186126, an analogue of indolidan (LY195115), to cardiac membranes enriched in sarcoplasmic reticulum vesicles.

Raymond F. Kauffman, B G Utterback, David W. Robertson · Circulation Research · 1989 · 14 citations · Full text

Cardiac Muscle, Proteinlipid Interaction, Pharmacotherapy +19